Occurrence of second primary malignancies in man-a second look

Cancer Treatment Reviews

Volumn 12, Issue 2, 1985, Pages 77-94

  Henne, T ^a   Schmahl D ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; AZATHIOPRINE; BLEOMYCIN; CARCINOGEN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; HYDROXYUREA; LOMUSTINE; LYMPHOCYTE ANTIBODY; MELPHALAN; METHOTREXATE; PREDNISONE; PROCARBAZINE; PYRIDOSTIGMINE; SEMUSTINE; TENIPOSIDE; THIOTEPA; VINBLASTINE; VINCRISTINE;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CARCINOGENESIS; CHEMICAL CARCINOGENESIS; DRUG DOSE; DRUG THERAPY; HUMAN; LEUKEMOGENESIS; MULTIPLE CANCER; REVIEW; THERAPY;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMAN; MALE; MIDDLE AGE; NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; RADIOTHERAPY; TIME FACTORS;

EID: 0022362337     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/0305-7372(85)90001-5     Document Type: Article

References (71)

1. Complications of treatment of small cell carcinoma of the lung
2. Therapy-related leukemia
3. Development of a dysmyelopoietic syndrome in a hairy cell patient treated with Chlorambucil; cytogenetic and morphologic evaluations
4. Acute promyclocytic leukemia following ABVD (Doxorubicin, Bleomycin, Vinblastine and Dacarbazine) and radiotherapy for Hodgkin's disease
5. Therapy-related preleukemic syndrome
6. Noncarcinogenic chemotherapy with a combination of Vineristine, Methotrexate and 5-Fluorouracil (VMF) in rats
7. Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (Methyl-CCNU)
8. Second primary cancers following treatment of Hodgkin's disease
9. Acute leukemia following chemotherapy and radiation therapy-a report of 15 cases
10. MESNA (Natrium-2-Mercaptoethansulfonat): Prophylaxe der akuten urotoxischen Nebenwirkungen sowie der kanzerogenen Spatfolgen von Cyclophosphamid und Ifosfamid
11. MESNA (Natrium-2-Mercaptoethansulfonat): Prophylaxe der akuten urotoxischen Nebenwirkungen sowie der kanzerogenen Spatfolgen von Cyclophosphamid und Ifosfamid
12. MESNA (Natrium-2-Mercaptoethansulfonat): Prophylaxe der akuten urotoxischen Nebenwirkungen sowie der kanzerogenen Spatfolgen von Cyclophosphamid und Ifosfamid
13. Risk of leukemia in patients treated for Hodgkin's disease
14. Leukemic immunoblastic sarcoma after chemotherapy for Hodgkin's disease
15. Fibroblastic tumor of the urinary bladder after cyclophosphamide therapy
16. Kaposi's sarcoma complicating immunosuppressive therapy for angioimmunoblastic lymphadenopathy with dysproteinemia
17. Second malignancies complicating Hodgkin's disease: A Southwest Oncology Group 10-year followup
18. Hodgkin's disease in renal transplant recipients
19. Late side effects of chemotherapy in ovarian carcinoma
20. Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit
21. Secondary acute lymphoblastic leukemia in a case of CLL of three years duration
22. Two cases of acute leukemia following treatment for malignant glioma
23. Malignant lymphomas in a case of disseminated erythematosus lupus treated with cytotoxic agents
24. Cyclophosphamide therapy and oncogenic effect (letter to the editor)
25. Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma
26. Ependymoma, glioblastoma and acute leukemia in a child
27. Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer
28. Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma
29. Acute myeloblastic leukemia after cure of ovarian cancer
30. Acute myeloid leukemia following treatment of Hodgkin's disease
31. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease
32. Evolution of acute leukemia in a renal transplant patient—?
33. Fibrosarcoma associated with intensive chemotherapy for advanced germ cell testicular tumor
34. Chronic idiopathic thrombocytopenic purpura (ITP): Development of acute nonlymphocytic leukemia subsequent to treatment with cyclophosphamide
35. Second malignancies associated with chemotherapeutic agents
36. Sequelle gonadiqeus et leucemie aigue apres chimotherapie d'une maladie de Hodgkin
37. Breast carcinoma after cancer therapy in childhood
38. Histiocytic medullary reticulosis complicating chronic lymphatic leukemia: malignant or reactive?
39. Acute leukemia following intensive therapy for small-cell carcinoma of the lung
40. Invasive carcinoma of the renal pelvis following cyclophosphamide therapy for nonmalignant disease
41. Ultrastructural characteristics of therapy-related acute nonlymphocytic leukemia: evidence for a panmyelosis
42. Second malignancy after Cisplatin, Vinblastine and Bleomycin (PVB) chemotherapy
43. Urothelial carcinoma after Cyclophosphamide therapy
44. Acute leukemia developing after intensive chemotherapy for small cell cancer of the lung
45. Burkitt cell leukemia following therapy for Hodgkin's disease
46. Late effects of treatment of cancer in infancy
47. Acute nonlymphocytic leukemia, preleukemia and acute myeloproliferative syndrome secondary to treatment of other malignant diseases
48. Acute leukemia following a malignant teratoma in a child with Klinefelter's syndrome
49. T-cell lymphoblastic lymphoma with subsequent acute nonlymphocytic leukemia
50. Carcinogenicity of antineoplastic agents in man
51. Acute leukemia after successful chemotherapy for oat cell carcinoma
52. Hodgkin's disease and acute leukemia
53. Cancer and second leukemia
54. No increase in second tumors after cytotoxic chemotherapy for gestational trophoblastic tumors
55. Glioblastoma multiforme in a patient with acute lymphoblastic leukemia who received a marrow transplant
56. Transitional cell carcinoma of the ureter associated with Cyclophosphamide therapy for benign disease: A case report
57. Nebenwirkungen zytostatischer Therapie unter besonderer Berücksichtigung potentieller carcinogener Wirkungen
58. Carcinogenic action of low-dose cyclophosphamide given orally to SpragueDawley rats in a lifetime experiment
59. Occurrence of second tumors in man after anticancer drug treatment
60. Acute monocytic leukemia complicating combined-modality therapy for localized childhood Ewing's sarcoma
61. Chronic lymphocytic leukemia following treatment for Hodgkin's disease
62. Cytogenetic studies of preleukemic phases and of acute leukemia secondary to chemo- and/or radiotherapy
63. Teleangiectatic Kaposi's sarcoma-occurrence in a patient with thymoma and myasthenia gravis receiving long-term immunosuppressive therapy
64. Second malignancy complicating Hodgkin's disease
65. Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease
66. Acute myeloblastic leukemia following chemotherapy for mycosis fungoides
67. Melphalan-related leukemia in multiple myeloma
68. Bioassay program for carcinogenic hazards of cancer chemotherapeutic agents
69. Kaposi's sarcoma in a patient with dermatomyositis receiving immunosuppressive therapy
70. Muscular pseudotumor of the breast following doxorubicin and radiation therapy for oat cell carcinoma of the lung